Correlates of susceptibility to hepatitis b among people who inject drugs in Sydney, Australia

Journal of Urban Health

Volumn 89, Issue 5, 2012, Pages 769-778

  Deacon, Rachel M ^a,b   Topp, Libby ^b   Wand, Handan ^b   Day, Carolyn A ^a   Rodgers, Craig ^c   Haber, Paul S ^a,d   Van Beek, Ingrid ^c   Maher, Lisa ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Kirketon Road Centre ^*  (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Hepatitis B virus; Immunization; Intravenous; Public health; Substance abuse

Indexed keywords

HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; BLOOD; DISEASE PREDISPOSITION; DRUG USE; FEMALE; HEPATITIS B; HUMAN; MALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH SUBJECT; SEROLOGY; SEX RATIO; STANDARD; STATISTICAL MODEL; STATISTICS; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; DISEASE SUSCEPTIBILITY; DRUG USERS; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW SOUTH WALES; OPIATE SUBSTITUTION TREATMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUBJECTS; SEROLOGIC TESTS; SEX DISTRIBUTION; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84868192371     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-012-9680-z     Document Type: Article

References (44)

1. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010.
2. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales; 2010.
3. Australian Government Department of Health and Ageing. Australian immunisation handbook. 9th ed. Canberra; 2008.
4. Lugoboni F, Quaglio G, Civitelli P, Mezzelani P. Bloodborne viral hepatitis infections among drug users: The role of vaccination. Int J Environ Res Public Health. 2009; 6(1): 400-413.
5. Gidding HF, Warlow M, MacIntyre CR, et al. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine. 2007; 25 (51): 8637-8641. (Pubitemid 350199587)
6. Tawk HM, Vickery K, Bisset L, Selby W, Cossart YE. The impact of hepatitis B vaccination in a Western country: Recall of vaccination and serological status in Australian adults. Vaccine. 2006; 24(8): 1095-1106. (Pubitemid 43202255)
7. Fattovich G. Natural history of hepatitis B. J Hepatol. 2003; 39(Suppl 1): S50-S58. (Pubitemid 37222647)
8. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: A large community-based linkage study. Lancet. 2006; 368(9539): 938-945. (Pubitemid 44331386)
9. National Centre in HIV Epidemiology and Clinical Research. Australian NSP Survey National Data Report 2005-2009. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales; 2010.
10. Maher L, Chant K, Jalaludin B, Sargent P. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia. J Gastroenterol Hepatol. 2004; 19(10): 1114-1120. (Pubitemid 39371252)
11. Day CA, White B, Dore GJ, et al. Hepatitis B virus among injecting drug users in Sydney, Australia: Prevalence, vaccination and knowledge of status. Drug Alcohol Depend. 2010; 108(1-2): 134-137.
12. Miller ER, Hellard ME, Bowden S, Bharadwaj M, Aitken CK. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. J Infect. 2009; 58(5): 375-382.
13. Crofts N, Aitken CK. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995. Med J Aust. 1997; 167(1): 17-20. (Pubitemid 27317522)
14. Ramasamy P, Lintzeris N, Sutton Y, Taylor H, Day CA, Haber PS. The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic. Addiction. 2010; 105(2): 329-334.
15. Macdonald V, Dore GJ, Amin J, van Beek I. Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre. Sex Health. 2007; 4(1): 27-30.
16. Topp L, Day C, Dore GJ, Maher L. Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: A review. Drug Alcohol Rev. 2009; 28(6): 669-675.
17. Amesty S, Ompad DC, Galea S, et al. Prevalence and correlates of previous hepatitis B vaccination and infection among young drug-users in New York City. J Community Health. 2008; 33(3): 139-148.
18. de la Fuente L, Toro C, Brugal MT, et al. Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy "don't ask, draw a blood sample, vaccinate and try to schedule another visit". J Clin Virol. 2007; 38(1): 87-90. (Pubitemid 44895604)
19. Lo Re V III, Frank I, Gross R, et al. Self-reported hepatitis B and C virus infections had low sensitivity among HIV-infected patients. J Clin Epidemiol. 2007; 60(3): 294-299. (Pubitemid 46205178)
20. Kuo I, Mudrick Daniel W, Strathdee Steffanie A, Thomas David L, Sherman Susan G. Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug users. Clin Infect Dis. 2004; 38(4): 587-590. (Pubitemid 38250972)
21. Best D, Noble A, Finch E, Gossop M, Sidwell C, Strang J. Accuracy of perceptions of hepatitis B and C status: Cross sectional investigation of opiate addicts in treatment. Br Med J. 1999; 319: 290-291. (Pubitemid 29353942)
22. Schlicting EG, Johnson ME, Brems C, Wells RS, Fisher DG, Reynolds G. Validity of injecting drug users' self report of hepatitis A, B, and C. Clin Lab Sci. 2003; 16(2): 99-106.
23. Rhodes T, Hunter GM, Stimson GV, et al. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: Injecting careers, positivity and risk behaviour. Addiction. 1996; 91(10): 1457-1467. (Pubitemid 26362774)
24. Maher L, Barnes K, Topp L, Day C, (on behalf of the Hepatitis Acceptability and Vaccine Incentives Trail-HAVIT Group). Use of incentives to increase vaccination uptake and completion in injecting drug users. 11th National Immunisation Conference; September 2008; Gold Coast.
25. Deacon R, Day C, Topp L, et al. Using financial incentives to increase hepatitis B immunisation completion in people who inject drugs: A randomised controlled trial. Australasian Professional Society on Alcohol and other Drugs Conference; Darwin: Drug Alcohol Rev; 2009:A13.
26. Deacon RM, Topp L, Wand H, et al. Correlates of hepatitis B vaccination status among injecting drug users: A comparison of eligible and ineligible participants in the HAVIT trial. 7th Australasian Viral Hepatitis Conference; September 2010; Melbourne.
27. Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computerassisted self-interviewing: Utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol. 2000; 152(2): 99-106. (Pubitemid 30463656)
28. Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial. Lancet. 1999; 353(9165): 1657-1661. (Pubitemid 29224522)
29. Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995; 90(5): 607-614.
30. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, GrantM. Development of the Alcohol Use Disorders Identification Test (AUDIT):WHOCollaborative Project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993; 88(6): 791-804. (Pubitemid 23194530)
31. MacDonald MA, Wodak AD, Dolan KA, van Beek I, Cunningham PH, Kaldor JM. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Med J Aust. 2000; 172(2): 57-61. (Pubitemid 30048541)
32. Kaye S, Darke S. Determining a diagnostic cut-off on the Severity of Dependence Scale (SDS) for cocaine dependence. Addiction. 2002; 97(6): 727-731. (Pubitemid 34620593)
33. Ross J, Teesson M, Darke S, et al. The characteristics of heroin users entering treatment: Findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev. 2005; 24(5): 411-418. (Pubitemid 43024040)
34. Winstock AR, Anderson CM, Sheridan J. National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia. Med J Aust. 2006; 184(11): 560-562. (Pubitemid 43950025)
35. van Beek I. Case study: Accessible primary health care-a foundation to improve health outcomes for people who inject drugs. Int J Drug Policy. 2007; 18(4): 329-332.
36. Day CA, Islam M, White A, Reid SE, Hayes S, Haber PS. Development of a nurse-led primary healthcare service for injecting drug users in inner-city Sydney. Aust J Prim Health. 2011; 17(1): 10-15.
37. Huang L, Gilbert M-L, Rossi M, et al. Trends in vaccine-induced immunity to hepatitis B among Canadian street-involved youth. J Urban Health. 2010; 87(2): 337-348.
38. Lum PJ, Hahn JA, Shafer KP, et al. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco. J Viral Hepat. 2008; 15(3): 229-236. (Pubitemid 351143743)
39. Smith JA, Braunack-Mayer A, Wittert G. What do we know about men's help-seeking and health service use? Med J Aust. 2006; 184(2): 81-83. (Pubitemid 43174199)
40. Galdas PM, Cheater F, Marshall P. Men and health help-seeking behaviour: Literature review. J Adv Nurs. 2005; 49(6): 616-623. (Pubitemid 40417364)
41. Green CA, Pope CR. Gender, psychosocial factors and the use of medical services: A longitudinal analysis. Soc Sci Med. 1999; 48(10): 1363-1372. (Pubitemid 29197338)
42. Kuo I, Sherman SG, Thomas DL, Strathdee SA. Hepatitis B virus infection and vaccination among young injection and non-injection drug users: Missed opportunities to prevent infection. Drug Alcohol Depend. 2004; 73: 69-78. (Pubitemid 37542480)
43. Seal KH, Edlin BR, Ochoa KC, Tulsky JP, Moss AR, Hahn JA. Risk of hepatitis B infection among young injection drug users in San Francisco: Opportunities for intervention. West J Med. 2000; 172(1): 16-20.
44. Justice Health. Justice health Area Health Service Plan 2010 and Beyond. Sydney: NSW Department of Health; 2009.